BrightSpring Health Analyst Price Targets - Benzinga

BrightSpring Health Services Inc

BTSGNASDAQ

Trade with Public

Trade with Public

$68.81

2.553.85%

Últ. Act.: Nov 3, 1:32 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

BrightSpring Health Analyst Price Targets - Benzinga

BrightSpring Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for BrightSpring Health (BTSG).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

1S.Buy

17Buy

1Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$59Upside to Avg. PT-15.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	Guggenheim	Jason Cassorla	PT Raise	Buy	$81→$84
Nov 2, 2026	UBS	A.J. Rice	PT Raise	Buy	$85→$92
Nov 2, 2026	Leerink Partners	Whit Mayo	PT Raise	Outperform	$72→$92
Nov 2, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$81→$84
Nov 2, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$78→$82
Aug 13, 2026	BTIG	David Larsen	Maintained	Buy	$90
Aug 3, 2026	BTIG	David Larsen	Maintained	Buy	$90
Jul 14, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$71→$80
Jul 14, 2026	Keybanc	Matthew Gillmor	PT Raise	Overweight	$60→$80
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$61→$78
Jul 13, 2026	Guggenheim	Jason Cassorla	Initiate	Buy	$81
Jul 10, 2026	Raymond James	Parker Snure	Initiate	Outperform	$80
Jul 8, 2026	UBS	A.J. Rice	PT Raise	Buy	$63→$85
Jul 2, 2026	B of A Securities	Kevin Fischbeck	PT Raise	Buy	$66→$77
Jun 22, 2026	BTIG	David Larsen	PT Raise	Buy	$65→$90
Jun 18, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$65→$81
Jun 8, 2026	Goldman Sachs	Scott Fidel	Initiate	Buy	$71
Jun 2, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$62→$71
May 6, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$48→$62
May 5, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$52→$61

Analyst Ratings News

PRO
Guggenheim Maintains Buy on BrightSpring Health, Raises Price Target to $84

Guggenheim analyst Jason Cassorla maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.

Benzinga Newsdesk

PRO
UBS Maintains Buy on BrightSpring Health, Raises Price Target to $92

UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $85 to $92.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on BrightSpring Health, Raises Price Target to $92

Leerink Partners analyst Whit Mayo maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $72 to $92.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on BrightSpring Health, Raises Price Target to $84

TD Cowen analyst Charles Rhyee maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $82

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $78 to $82.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target

BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.

Benzinga Newsdesk